Nkarta, Inc. Analytics - Traffic, Statistics and Competitor Tracking


Nkarta, Inc. Website Screenshot

http://www.nkartatx.com

Nkarta, Inc. Company Intro

Nkarta seeks to improve upon the efficacy of cell therapy, making it more potent, better tolerated and more rapidly available to a broad population of patients with a variety of hematologic and solid tumor malignancies.

Industry

Healthcare

Nkarta, Inc. Headquaters

6000 Shoreline Court
South San Francisco,94080
United States


Nkarta, Inc. Share price

20 Oct 2020 02:10 GMT

$32.27

0.27 (0.84 %)


Nkarta, Inc. Market cap

$986.44 M


WMC RANKING

2020

Nkarta, Inc. # 300

Biotechnology



Latest Nkarta, Inc. News

News 19 Oct 2020

Natural Killer Cells Therapeutics Market Report 2020 (COVID-19 Impact Analysis) By Segmentations, Key Company Profiles & Demand Forecasts to 2020 – 2026

Ziopharm Oncology, Inc. Nkarta Therapeutics. In Chapter 11 and 13.3, on the basis of types, the Natural Killer Cells Therapeutics market from 2015 to 2026 is ...

News 19 Oct 2020

Natural Killer Cells Therapeutics Market Report 2020 (COVID-19 Impact Analysis) By Segmentations, Key Company Profiles & Demand Forecasts to 2020 – 2026

Ziopharm Oncology, Inc. Nkarta Therapeutics. In Chapter 11 and 13.3, on the basis of types, the Natural Killer Cells Therapeutics market from 2015 to 2026 is ...

News 19 Oct 2020

Natural Killer Cells Therapeutics Market Report 2020 (COVID-19 Impact Analysis) By Segmentations, Key Company Profiles & Demand Forecasts to 2020 – 2026

Ziopharm Oncology, Inc. Nkarta Therapeutics. In Chapter 11 and 13.3, on the basis of types, the Natural Killer Cells Therapeutics market from 2015 to 2026 is ...

WMC Market Score


WMC Market to Revenue Score


Revenue Total Social Followers Total Social Posts Search Volume Digital Footprint Size Digital change (New Pages) WMC Market Score
Nkarta, Inc. 0.00 0 0 0 0 0 0
Alexion Pharmaceuticals, Inc. 100 13.14 100 19 0 0 99.09
Vertex Pharmaceuticals Incorporated 97.58 100 3.66 30 0 0 100
3SBio Inc. 96.05 0 0 4 0 0 3.03
Incyte Corporation 40.27 14.26 7.07 100 0 0 91.10

Nkarta, Inc. Market Financials


Revenue, Expenses, Profit


Company Revenue Expense Profit Market Cap WMC Sector Score
Nkarta, Inc. $0 $34,321 $-72,926 $986.44M 300
Alexion Pharmaceuticals, Inc. $5,536,800 $2,523,000 $846,100 $26.687B 1
Vertex Pharmaceuticals Incorporated $5,402,685 $2,634,428 $2,080,775 $57.436B 2
3SBio Inc. ¥5,318,091 ¥3,085,221 ¥973,717 ¥19.572B 3
Incyte Corporation $2,229,409 $1,622,822 $446,906 $19.193B 4

Market Analytics


Company Search vs Top 4 Industry Competitors



Total Nkarta, Inc. Social Followers vs Top 4 Industry Competitors



Nkarta, Inc. Post vs Top 4 Industry Competitors